Description

Octreotide (brand name Sandostatin, Novartis Pharmaceuticals) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Octreotide

Basic Part Properties

Part Name
Octreotide
Part Display Name
Octreotide
Part Type
Component (Describes the core component or analyte measured)
Created On
2009-11-18
Construct for LOINC Short Name
Octreotide

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP97954-9
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP97954-9

Language Variants Get Info

TagLanguageTranslation
et-EEEstonian (Estonia)Oktreotiid
es-ESSpanish (Spain)Octreotida
it-ITItalian (Italy)Octreotide
tr-TRTurkish (Turkey)Oktreotid
ru-RURussian (Russian Federation)Окреотид
nl-NLDutch (Netherlands)octreotide
fr-BEFrench (Belgium)Octréotide
fr-FRFrench (France)Octréotide
zh-CNChinese (China)奥曲肽
Synonyms: Octreotide;善得定;奥曲
pl-PLPolish (Poland)Oktreotyd
el-GRGreek (Greece)Οκτρεοτίδη
Synonyms: Οκτρεοτίδη